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BACKGROUND: Leakage from colonic anastomosis is a major complication causing increased mortality and
morbidity. Ischemia is a well-known cause of this event. This study was designed to investigate the effects of
adrenomedullin on the healing of ischemic colon anastomosis in a rat model.
METHODS : Standardized left colon resection 3 cm above the peritoneal reflection and colonic anastomosis were
performed in 40 Wistar rats that were divided into four groups. To mimic ischemia, the mesocolon was ligated 2 cm
from either side of the anastomosis in all of the groups. The control groups (1 and 2) received no further treatment.
The experimental groups (3 and 4) received adrenomedullin treatment. Adrenomedullin therapy was started in the
perioperative period in group 3 and 4 rats (the therapeutic groups). Group 1 and group 3 rats were sacrificed on
postoperative day 3. Group 2 and group 4 rats were sacrificed on postoperative day 7. After careful relaparotomy,
bursting pressure, hydroxyproline, malondialdehyde, interleukin 6, nitric oxide, vascular endothelial growth factor,
and tumor necrosis factor alpha levels were measured. Histopathological characteristics of the anastomosis were
analyzed.
RESULTS : The group 3 animals had a significantly higher bursting pressure than group 1 (p,0.05). Hydroxyproline
levels in group 1 were significantly lower than in group 3 (p,0.05). The mean bursting pressure was significantly
different between group 2 and group 4 (p,0.05). Hydroxyproline levels in groups 3 and 4 were significantly
increased by adrenomedullin therapy relative to the control groups (p,0.05). When all groups were compared,
malondialdehyde and nitric oxide were significantly lower in the control groups (p,0.05). When vascular
endothelial growth factor levels were compared, no statistically significant difference between groups was
observed. Interleukin 6 and tumor necrosis factor alpha were significantly decreased by adrenomedullin therapy
(p,0.05). The healing parameters and inflammatory changes (e.g., granulocytic cell infiltration, necrosis, and
exudate) were significantly different among all groups (p,0.05).
CONCLUSION : Adrenomedullin had positive effects on histopathologic anastomotic healing in this experimental
model of ischemic colon anastomosis.
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INTRODUCTION
Colon resections and anastomosis are frequent surgical
procedures performed in general surgery. Although these are
reliable operations, leakage of anastomoses can lead to serious
complications, which may cause death.1-3 Colonic mucosal
blood flow, the anastomosis technique, inflammation, the age
of the patient, the nutritional state of the patient, additional
diseases, medications, and the type of operation can affect the
leakage of colonic anastomoses.4 In particular, insufficient
colonic mucosal blood flow, the quantity of bacteria coloniza-
tion, chemotherapy agents, radiation, and corticosteroid use
may cause complications in colon anastomosis.5 Although the
most important factors for success in anastomotic surgery are
surgical experience and technique, some additional drugs and
tools are also necessary in certain circumstances. Colonic
anastomoses performed in an ischemic and contaminated
abdomen can be particularly problematic, and the risk of
anastomotic leakage increases under such circumstances.6
Various drugs and methods have been tried to reduce
anastomotic leakage, but no agents are currently known to
prevent ischemic colonic anastomotic leakage effectively.
Adrenomedullin (ADM), which was initially obtained
from pheochromocytoma during an investigation into the
effects of certain peptides on the levels of thrombocyte
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cAMP, is a peptide consisting of 52 amino acids.7-9 ADM
levels differ according to disease state. It has strong
hypotensive and vasodilator effects in vivo following
intravenous administration. It promotes non-adrenergic
and non-cholinergic vasodilator responses in systematic
and pulmonary blood vessels via endothelium-dependent
and endothelium-independent mechanisms. Thus, blood
flow to the heart, kidneys, brain, and lungs increase when
ADM levels rise.10 ADM mRNA was discovered in
duodenal, small intestinal, cecal, and colonic mucosae by
Kita et al.11 in 1993. They considered ADM to be part of
gastrointestinal endocrine system. Hinson et al.12 offered a
more precise definition of the endocrine cells present in the
gastrointestinal system and proposed that these cells
comprised the subgroup of enterochromaffin cells of the
gastrointestinal system. Isumi et al. reported that ADM was
also secreted from endothelial and smooth muscle cells and
played a role in the induction of numerous molecules, such
as TNF-a and IL-1.13,14
Despite the numerous well-known effects of ADM, its
effects on the gastrointestinal system are not entirely
understood. The aim of this study is to investigate the effect
of ADM, a strong vasoactive agent, on ischemic colon
anastomoses and oxidative damage in colonic mucosa.
METHODS
This study was performed between October 2008 and
January 2009 in the laboratory of Istanbul University,
Institute of Experimental Medical Research after approvals
were obtained from the animal ethics committee.
Animals
A total of 40 female Wistar albino rats were used in the
study. Their mean weight was 220 g. Rats were placed in
individual cages with alternate light and dark cycles of
12 hours. Experimental animals were pre- and postopera-
tively fed a normal diet. Rats were randomly divided into
two main groups: a control group, which received ischemic
colonic anastomosis only, and an experimental group, which
received both ischemic colonic anastomosis and ADM.
The control group (n = 16) was divided into two sub-
groups: group 1 (n = 8, sacrificed on postoperative day 3)
and group 2 (n = 8, sacrificed on postoperative day 7). The
experimental group (n= 16) was also divided into two
subgroups: group 3 (n= 8, sacrificed on postoperative day 3)
and group 4 (n= 8, sacrificed on postoperative day 7).
Surgical Procedure
Following intraperitoneal injection of ketamine 10 mg/
kg, the incision sight for a median laparotomy was shaved
and cleaned. The incision line was painted with batticon
solution, and a median laparotomy was performed. The
distal portion of the left colon was located, and a 1-cm-long
colonic segment was removed. Blood vessels supplying
this site were ligated 2 cm proximal and 2 cm distal to the
anastomotic site after the fecal content was removed. Then
an end-to-end anastomosis was performed with a single-
layer 6/0 polypropylene suture, and the abdomen was
closed. The animals were permitted to eat 24 hours after the
surgery.
Rats in groups 1 and 3 were sacrificed on day 3, and rats
in groups 2 and 4 were sacrificed on day 7 by administration
of a ketamine overdose via cardiac puncture. Then the
animals were assessed. Sampling for histopathological and
biochemical examinations was performed following the
measurement of the anastomotic bursting pressure in all of
the rats.
Treatment with Adrenomedullin
Two micrograms per day of rat ADM were administered
subcutaneously to the group 3 and 4 rats beginning during
the early postoperative period and continuing for three days
(Adrenomedullin 1-50, Rat 100 micrograms, Calbiochem,
U.S. and Canada).
Measurement of Bursting Pressure
A second laparotomy was performed through a median
incision on the group 1 and group 3 rats on postoperative
day 3 and on the group 2 and group 4 rats on postoperative
day 7. After the animals were euthanized, the anastomosis
site was identified by the presence of polypropylene
sutures. The segment containing the anastomotic site was
separated without dissecting the adhesions too much, and a
2 cm proximal and 2 cm distal side segment was prepared.
Later, the proximal bowel segment was cannulated and
connected to an insufflation pump, and the distal part was
also ligated. Insufflation was initiated in a container filled
with physiological serum. The anastomotic bursting pres-
sure was recorded for all of the study animals by noting the
pressure at the moment the first bubble was observed.
Measurement of Hydroxyproline
Hydroxyproline was measured after storing the peria-
nastomotic bowel segment at -70 C˚. Hydroxyproline was
evaluated spectrophotometrically at 560 nm using the
Prockop and Kivirikko technique.15
Assessment of Oxidative Damage
Tissue samples were homogenized in 1/5 (w/v) phos-
phate-buffered saline solution after being cut into small
pieces. Then, the values were measured using a Shimada
1601 UV/Vis spectrophotometer (Shimada, Japan) accord-
ing to the method of Lowry and Rosebrough. Protein
concentration was determined according to the Lowry
method.16
Measurement of Malondialdehyde (MDA)
MDA was measured using the tributyric acid method.
Iron sulfate (1 mmol/L) was added at pH 2.0. Absorption
was measured at 535 nm. The normal range of MDA
concentrations in tissue was determined to be ,1.0 mmol/
L/mg tissue.
Measurement of Nitric Oxide (NO)
A colorimetric method was used to measure NO
(Boehringer Mannheim kit, cat no: 175 6281). Typical values
of NO concentration in tissue were ,0.5 pg/ml/mg tissue.
Measurement of Vascular Endothelial Growth
Factor (VEGF)
Plaques covered with DiaClone anti-polyclonal animal
vascular endothelial growth factor were used. These tests
were performed using an automatic Best 2000 (Biokit Elisa
System, USA) microelisa. Normal values for VEGF concen-
tration in tissue were ,50 pg/ml/mg tissue.
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Measurement of TNF (Tumor Necrosis Factor) Alpha
and IL-6 (Interleukin-6)
TNF-a and IL-6 levels in tissue homogenate were
measured by enzyme-linked immunosorbent assay (ELISA),
(Quantikine Sensitivity Human, R&D Systems, USA). Typical
values for IL-6 and TNF-a concentration in tissue were
,3.0 pg/ml/mg and ,3.5 ng/ml/mg, respectively.
Histopathological Evaluations
Tissues were fixed in 10% formaldehyde for histopatho-
logical examination, stained with hematoxylin-eosin, and
evaluated under x40, x100, x200, and x400 magnification.
Recovery parameters and inflammatory changes were
evaluated semiquantitatively. These included granulocyte
cell infiltration, fibroblast cell infiltration, necrosis, exudate
and new capillary formation. The results of each evaluation
were scored between 0 and 3.
Statistical Evaluation
Quantitative results were expressed as the mean ¡
standard deviation. The Mann–Whitney U test was used
to make comparisons between groups. Multiple compar-
isons and multiple assessments between groups were
performed using Tukey’s post-hoc HSD test. P-values of
,0.05 were considered statistically significant. Statistical
Package for Social Sciences (SPSS) for Windows 15.0 (SPSS
Inc., Chicago, IL, USA) was used for statistical calculations.
RESULTS
Rats were sacrificed on day 3 or 7. Anastomotic leakage
was detected in one rat in each group. These rats were
excluded from evaluation. The mean bursting pressure and
data obtained from the biochemical assessment are dis-
played in Tables 1 and 2.
In the statistical assessment, bursting pressure was
significantly higher on day 3 in the adrenomedullin-treated
group (group 3) than in the nontreated group (group 1).
Additionally, when the hydroxyproline levels were com-
pared, group 3 was significantly higher (p= 0.007). When the
mean bursting pressures and hydroxyproline levels were
compared between groups 2 and 4 on day 7, the difference
between bursting pressures were not significant; however,
the adrenomedullin-treated group did show significantly
higher hydroxyproline levels (p= 0.03).
With regard to the markers of the oxidative damage,
MDA and NO levels were significantly lower in the
adrenomedullin-treated group than in the nontreated
groups on days 3 and 7 (MDA day 3 p= 0.005, MDA day 7
p= 0.003, NO day 3 p= 0.003, and NO day 7 p= 0.002).
When VEGF levels were compared, no statistically
significant difference was observed between the treated
and control groups on either day 3, or day 7 (p= 0.6 and
p= 0.56, respectively).
A graph comparing MDA levels for each pair of groups is
displayed in Figure 1.
Histopathological differences between groups on day 3
(groups 1 and 3) and on day 7 (groups 2 and 4) are shown in
Tables 3 and 4.
The histopathological parameters, including inflammatory
variations, mononuclear cell infiltration, epithelialization,
capillary formation, necrosis, exudation, and fibroblastic
activity displayed significant variations among all of the
groups. Moderate or very strong infiltration of neutrophils
was observed in all of the rats in groups 1 and 2, in three rats
(37.5%) in group 3, and in three rats (42%) in group 4.
Additionally, the infiltration of neutrophils was significantly
higher in the untreated groups than in the adrenomedullin-
treated groups on both day 3 and 7. Moderate or strong
capillary formation was observed in six (75%) rats in group 1,
in seven (90%) rats in group 2, in six (75%) rats in group 3, and
in five (60%) rats in group 4. When capillary formation was
compared between groups, no statistically significant differ-
ence was observed on either day 3, or day 7. Moderate or high
levels of necrosis were observed in all of the rats in groups 1
and 2. The levels of necrosis in groups 3 and 4 were
significantly lower than in groups 1 and 2, respectively
Table 1 - Biochemical assessment and bursting pressures in groups 1 and 3, sacrificed on postoperative day 3.
Parameters Group 1 Group 3
Mean SD Mean SD p-value
IL-6 (pg/ml/mg tissue) 3.18 ¡0.60 2.67 ¡0.32 0.032
TNF-a (ng/ml/mg tissue) 3.77 ¡0.25 3.35 ¡0.37 0.032
MDA (mg/ml/mg tissue) 1.67 ¡0.25 1.10 ¡0.21 0.005
NO (pg/ml/mg tissue) 0.68 ¡0.17 0.37 ¡0.09 0.003
VEGF (pg/ml/mg tissue) 40.75 ¡8.10 42.75 ¡6.90 0.607
Hydroxyproline (mg/tissue) 228 ¡16.46 253.75 ¡15.11 0.007
Bursting pressure (mmHg) 130.25 ¡2.96 136.50 ¡1.92 ,0.001
Table 2 - Biochemical assessment and bursting pressures in groups 2 and 4, sacrificed on postoperative day 7.
Parameters Group 2 Group 4
Mean SD Mean SD p-value
IL-6 (pg/ml/mg tissue) 3.31 ¡0.38 2.88 ¡0.16 0.013
TNF-a (ng/ml/mg tissue) 3.52 ¡0.18 3.23 ¡0.23 0.048
MDA (mg/ml/mg tissue) 1.48 ¡0.21 1.09 ¡0.11 0.003
NO (pg/ml/mg tissue) 2.01 ¡0.17 1.26 ¡0.25 0.002
VEGF (pg/ml/mg tissue) 46.42 ¡7.54 48.42 ¡4.19 0.564
Hydroxyproline (mg/tissue 345 ¡43.96 397.14 ¡29.24 0.013
Bursting pressure (mmHg) 148.28 ¡6.23 177.14 ¡5.89 ,0.001
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(p,0.001 for each). Moderate or very strong fibroblastic
activity was observed in two (25%) group 1 rats, in six (80%)
group 2 rats, in five (65%) group 3 rats and in six (60%) group
4 rats.Moderate or severe epithelializationwas observed in all
of the groups. However, a statistically significant difference
was not observed between groups 1 and 3 or groups 2 and 4 in
either epithelialization or fibroblastic activity.
DISCUSSION
Anastomotic leakage and anastomotic dehiscence increase
mortality and morbidity and have serious consequences in
colorectal surgery. Despite advancements in suture techni-
ques and suture materials, anastomotic leakage occurs in 0 to
35% of colorectal surgeries.16 Although numerous local and
systemic factors are responsible for this high incidence,
intestinal blood flow, oxygenation, blood transfusion, surgi-
cal technique, suture materials, fecal contamination, perito-
neal sepsis, anastomotic dehiscence, intestinal obstruction,
and necrosis can all be considered directly related causes.
The healing of colonic anastomosis is a complex pro-
cess correlated with inflammation, re-epithelialization and
collagen metabolism. During the primary inflammatory
response, including the first stage of anastomosis healing,
collagen lysis begins with the release of cytokines and the
migration of leukocytes. Local bacterial contamination in the
environment results in re-epithelialization and a secondary
inflammatory response at the wound boundaries. Collagen
lysis continues during the secondary inflammatory phase
as well. Anastomotic tensile strength is affected by the
decrease in collagen lysis, new collagen synthesis and
the number of bridges between collagen fibers. Primary
inflammatory response, mucosal re-epithelialization, sec-
ondary inflammatory response and collagen maturation
speed are the most important factors in anastomotic healing.
Anastomotic tensile strength is based on collagen fibril
settling within the submucosal layer.16
Agents that effectively promote the pathophysiological
process of healing have been investigated in studies of colon
anastomosis. These agents either induce wound healing or
increase vascularization and decrease the septic state.
Generally, local blood flow in the anastomotic site is the
most important factor in anastomotic healing. The occurrence
of anastomotic leakage in ischemic colonic anastomosis is
about 35%, which is higher than that of normal anastomosis.
Thus, we chose to use ischemic colonic anastomosis as an
experimental model in our study. Clinically, ischemic colonic
anastomosis often occurs in operations performed under
urgent conditions or in operations required for reasons other
than intestinal problems, such as aortic surgery or during the
resection of large tumors involving the intestinal mesentery
when intestinal nutrition is affected.17 An agent that
effectively increases anastomotic reliability during such
conditions has not yet been found.
Numerous agents to treat anastomotic leakage have been
examined. Aslan et al.18 used mesalamine (5-ASA) to
improve healing at the site of colonic anastomosis due to
its anti-inflammatory and oxygen free radical–scavenging
effects. C¸evikel et al.19 also examined the role of high-dose
ascorbic acid supplementation and investigated the effects
of ascorbic acid supplementation on collagen accumulation
and the inflammatory response. They observed that ascorbic
acid supplementation had a positive effect on the improve-
ment of colonic anastomoses. In another study, Marc et al.20
found that doxycycline supported the matrix structure and
increased matrix metalloproteinase and collagen accumula-
tion at the anastomotic site.
The description of ADM by Kitamura et al.21 in 1993
attracted the attention of numerous investigators. In 2001
Hay and Smith22 conducted receptor typing of ADM. They
were of the opinion that this receptor type behaved as
a calcitonin-related peptide receptor. Its presence was
observed in the duodenal, jejunal, stomach, cecal, and colon
mucosae, as well as in smooth muscles. In this study, we
assess the role of ADM in ischemic colonic anastomosis. To
date, the effect of ADM on intestinal mucosae has remained
unclear. Kitamura et al.21 reported that ADM is secreted
from a subgroup of enterochromaffin cells in the gastro-
intestinal system. Mulder et al. reported the insulinotropic
effects of ADM on the gastrointestinal system. Clemeti et
Figure 1 -MDA levels in groups 1 and 3 and in groups 2 and 4 are
significantly different (p,0.05 for each).
Table 3 - Histopathological differences between groups 1 and 3, sacrificed on postoperative day 3.
Parameters (scores) Group 1 Group 3
Mean SD Mean SD p-value
Neutrophil infiltration 2.65 ¡0.51 1.38 ¡0.51 0.001
Mononuclear infiltration 1.88 ¡0.64 1.25 ¡0.46 0.054
Fibrobastic activity 1.25 ¡0.46 1.88 ¡0.83 0.072
Epithelization 0.63 ¡0.51 1.00 ¡0.75 0.068
Necrosis 2.38 ¡0.51 0.88 ¡0.83 0.001
Capillary formation 2 ¡0.75 2.13 ¡0.83 0.65
Exudation scoring 2.75 ¡0.46 1.13 ¡0.35 0.001
Serositis scoring 2.5 ¡0.53 1.38 ¡0.51 0.001
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al.23 determined that ADM hampered gastric mucosal
damage and published its effects on the gastric artery in
2002. ADM is a strong stimulator of angiogenesis whose
secretion is required for normal vascular development;
however, its excessive release may also be either a cause or a
consequence of tumor development.24 ADM is secreted
from microvascular endothelial cells during hypoxia and
ischemia.25 The effects of ADM on DNA synthesis and cell
proliferation, especially in rats, suggest that ADM has a
strong antiproliferative effect via cAMP.26
The vasoactive effects of ADM are its most well
established, as it is known to increase blood flow to brain,
heart, and kidneys and to cause hypotension following
intravenous administration.27
Additionally, we predicted that ADM could negatively
affect colonic blood flow due to its hypotensive effects.
However, less oxidative damage was observed with ADM
administration, even though it inducedmore revascularization
than was seen in the control groups. Moreover, hydroxypro-
line levels, determined spectrophotometrically, increased
significantly in the ADM-treated groups. This demonstrates
that ADM’s endothelial protective effects and its ability to
reduce oxidative damage without increasing neovasculariza-
tion at ischemic sites are dominant over the hypotensive effect
of ADM on the intestines. Additionally, necrosis and
inflammation were less prevalent in the ADM-treated groups
than in the control groups. These differences were consistent
with the biochemical parameters observed in groups 3 and 4.
The effects of ADM on DNA synthesis and cell prolifera-
tion, especially in rats, have shown that ADM has a strong
antiproliferative effect via cAMP.27 However, whether the
vasodilatory and growth-inhibiting effects of ADM in
vascular cells are in contrast with the vasoconstrictor/
proliferative effects of endothelium and angiotensin II
remain to be determined.28
A typical dose of ADM to aid ischemic colonic anastomosis
healing has not been designated in the literature.We based our
ADMdose on those reported to be effective on ischemic tissue
in the literature, and this dose was given as a postoperative
continuation dose. To date, this investigation is the only study
performed in this field. Therefore, commenting on the results
with respect to dose and administration design (single dose or
continuous treatment) is rather difficult.
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